During atherogenesis, low density lipoprotein (LDL) particles bind to extracellular matrix proteoglycans in the arterial wall, become modified, and appear as aggregated and fused particles. Sphingomyelinase (SMase) and phospholipase A 2 (PLA 2 ) have been found in the arterial wall, and, moreover, lesional LDL shows signs of hydrolysis of both sphingomyelin and phosphatidylcholine. We have now studied the effects of these two lipolytic modifications on the aggregation and fusion of LDL particles by hydrolyzing the particles with Bacillus cereus SMase or bee venom PLA 2 . In addition, the binding strengths of the modified LDL to human aortic proteoglycans (PG) were analyzed on an affinity column. We found that SMase induced aggregation and fusion of LDL, but PLA 2 induced only aggregation of the particles. In addition, the SMase-induced aggregation and fusion of LDL was promoted by pretreatment of LDL with PLA 2 . Determination of the binding strengths of the hydrolyzed LDL revealed that mere lipolysis of LDL without aggregation or fusion, either by SMase or PLA 2 , did not affect the binding of the particles to PG. Aggregation and fusion of lipolyzed LDL particles, however, increased their strength of binding to PG. Active lysine residues in apolipoprotein B-100 (apoB-100) appear to be involved in the binding of LDL to PG, and, in fact, quantitative 13 C NMR analysis revealed that, in the fused LDL particles, the number of active lysine residues per apoB-100 moiety was increased. Moreover, aggregation and fusion of LDL increased the number of apoB-100 copies and, consequently, the number of active lysine residues per aggregate or fused particle. Our present findings therefore (i) show that treatment of LDL with SMase and PLA 2 generates modified LDL particles, which then bind to human aortic PG with increased strength, and (ii) suggest that SMase-and PLA 2 -induced aggregation and fusion of LDL are potential mechanisms leading to focal retention of extracellular lipid in the arterial wall.
In atherosclerosis, one important factor causing the retention of low density lipoprotein (LDL) 1 particles within the arterial wall is their binding to intimal proteoglycans (1, 2) . Indeed, complexes of apolipoprotein B-100 (apoB-100) containing lipoproteins and proteoglycans can be isolated from fatty streaks and fibrous plaques in the human aorta (3) . Since a subendothelial proteoglycan-rich layer is present in all arteries, the atherosclerotic areas have been suggested to contain proteoglycans with a unique structure that favors entrapment of LDL (4, 5) . Another possible cause of the focal accumulation of LDL-derived cholesterol is modification of the LDL in the atherosclerosis-prone intimal areas, with ensuing strengthened binding to proteoglycans. Of the potential modifications of LDL in the arterial intima, oxidation has been studied the most (6) . However, oxidation of LDL inhibits rather than augments the interaction between LDL and proteoglycans (7) . Another potential cause of LDL modification influencing the interaction between LDL and proteoglycans is proteolysis of the apoB-100 component of LDL. In fact, treatment of LDL with mast cell chymase (8) or ␣-chymotrypsin (9) increased the strength of LDL binding to proteoglycans. Treatment of LDL with these proteolytic enzymes induced fusion of the proteolyzed LDL particles (10, 11) , and the fused particles were found to bind more tightly than native LDL to proteoglycans (9) .
A third possible type of modification of LDL in the arterial intima is lipolysis. Lesional LDL particles and extracellular lipid droplets are relatively enriched in sphingomyelin (SM) (12, 13) , a finding suggesting hydrolysis of phosphatidylcholine (PC). In addition, aggregated lesional LDL contains ceramide, the lipolytic product of sphingomyelinase (SMase) (14) . These findings, together with the fact that both secretory SMase (15) and secretory phospholipase A 2 (PLA 2 ) (16 -18) have been found in the arterial intima, support the view that these lipolytic enzymes play a role in atherogenesis. After hydrolysis by either SMase or PLA 2 , LDL is taken up by macrophages in vitro (19, 20) . However, no studies have addressed the effects of these enzymes on the direct binding of LDL to proteoglycans.
In this study, we have examined the effects of hydrolysis of SM with Bacillus cereus SMase and hydrolysis of PC with bee venom PLA 2 on the morphology of LDL particles and on the interaction between LDL particles and human aortic proteoglycans. The distinct changes in the lipids of LDL induced by the two enzymes were found to lead to dissimilar aggregation/ fusion behavior of the modified LDL particles. Despite these differences, both modifications were found to increase the binding strength of LDL to human aortic proteoglycans.
EXPERIMENTAL PROCEDURES
Materials-Essentially fatty acid-free bovine serum albumin (BSA), ⑀-aminocaproic acid, PLA 2 (from bee venom), immobilized PLA 2 (from bee venom), and sphingomyelinase (from B. cereus) were from Sigma.
t-Butoxycarbonyl-L-[
3 H]methionine N-hydroxysuccinimidyl ester (the 3 H-labeling reagent) was from Amersham Pharmacia Biotech. Phenylmethylsulfonyl fluoride was from Boehringer Mannheim. Chondroitinases ABC and AC and the unsaturated chondro-disaccharide kit for high performance liquid chromatography were from Seikagaku Kogyo. [ 13 C]Formaldehyde (99% isotope enrichment) as a 20% solution in water was from Isotec Inc., and [
14 C]formaldehyde was from DuPont. NaCNBH 3 from Sigma was purified by recrystallization from dichloromethane before use (21) . Superose 6 HR 10/30 column and HiTrap NHS activated (1 ml) column were from Amersham Pharmacia Biotech. Bio-Gel A-5m gel filtration media was from Bio-Rad, and the 5-m NH 2 (0.3 ϫ 25 cm) column was from Spherisorb.
Preparation and Labeling of LDL-Human LDL (d ϭ 1.019 -1.050 g/ml) was isolated from plasma of healthy volunteers by sequential ultracentrifugation in the presence of 3 mM EDTA (22, 23) . 3 H-LDL was prepared by labeling the protein component of LDL by the BoltonHunter procedure (24) with a 3 H-labeling reagent, as described previously (25) . For each experiment, labeled LDL was diluted with unlabeled LDL to give the specific radioactivities indicated in the figure legends. The amounts of LDL are expressed in terms of its protein concentration.
Treatment of LDL with Phospholipase A 2 and Sphingomyelinase-LDL (1 mg/ml) was incubated with 95 ng/ml (50 milliunits/ml) SMase in 5 mM HEPES, 2 mM CaCl 2 , 5 mM MgCl 2 , and 140 mM NaCl, pH 7.4, or with 50 ng/ml (60 milliunits/ml) PLA 2 or 16 g/ml agarose beads containing 60 units/ml immobilized PLA 2 in the absence or presence of 2% (w/v) fatty acid-free BSA in 5 mM HEPES, 5 mM CaCl 2 , 2 mM MgCl 2 , and 140 mM NaCl, pH 7.4. After incubation at 37°C for the indicated times, lipolysis was stopped by addition of EDTA to give a final concentration of 10 mM. To separate the immobilized PLA 2 from LDL, the incubation mixtures were centrifuged at 2000 ϫ g for 5 min.
Analysis of Lipolyzed LDL-The turbidity of modified LDL (250 l) was measured at 430 nm, using a cuvette with a 1-cm light path with a Biochrom 4060 spectrophotometer (Amersham Pharmacia Biotech). The degree of lipolysis with SMase was determined as the amount of phosphocholine generated (26) , and the degree of lipolysis with PLA 2 was determined by measuring the amount of free fatty acids generated using a commercial kit (Nefa-C-kit, Wako Chemicals). For phospholipid analysis, lipid extracts of LDL (27) were chromatographed by TLC using chloroform/methanol/acetic acid/H 2 O (50:30:8:3.5, v/v). Individual phospholipid subclasses were visualized by dipping the TLC plate into a solution containing 3% copper acetate (w/v) and 8% phosphoric acid (w/v) and then heating the plate at 150°C for 20 min. The phospholipids were detected with an automatic plate scanner (CAMAG TLC Scanner 3). Protein was determined by the method of Lowry et al. (28) , with bovine serum albumin as standard.
Isolation of Aggregated/Fused LDL-The degree of aggregation and/or fusion of lipolyzed 3 H-LDL was determined by gel filtration chromatography. Aliquots corresponding to 100 -400 g of LDL in 100 -400 l were run through a Superose 6 HR 10/30 column in 5 mM Tris-HCl, 1 mM EDTA, and 150 mM NaCl, pH 7.4. The flow rate was 0.5 ml/min, and 500 -l fractions were collected. The degree of aggregation/ fusion of the 3 H-LDL (eluting in the void volume of the column) was determined by calculating the ratio of the radioactivity in fractions 14 -19 (void volume peak) to the total eluted radioactivity (fractions 14 -30) . The degree of aggregation/fusion is expressed in percent ((radioactivity in void volume/total eluted radioactivity) ϫ 100).
Preparation and Characterization of Aortic Proteoglycans-Proteoglycans from intima media of human aortas were obtained at autopsy within 24 h of accidental death and were prepared essentially by the method of Hurt-Camejo et al. (29) as described previously (7) . The disaccharide composition of the proteoglycans was analyzed after treatment with chondroitinase ABC and AC by high performance liquid chromatography using a 5-m NH 2 column (30) . The proteoglycan preparation used here contained 36% of chondroitin 6-sulfate, 52% of chondroitin 4-sulfate, and 12% of dermatan sulfate. Glycosaminoglycans were determined by the method of Bartold and Page (31) , and the amounts of the proteoglycans are expressed in terms of their glycosaminoglycan content. Modification of Lipolyzed LDL-LDL (2 mg) was lipolyzed for 12 h with SMase or PLA 2 as described above, and after lipolysis, the lysine residues of apoB-100 were modified by treatment of 1 mg of the lipolyzed LDL samples with acetic anhydride (32) .
Preparation of 13 C-Labeled LDL and 13 C-Labeled Lipolyzed LDL for NMR Spectroscopy-LDL (20 -40 mg, 2 mg/ml) was lipolyzed with PLA 2 or SMase as described above. After incubation at 37°C for 8 h, the samples were applied to a gel filtration column (Bio-Gel A-5m (2.6 ϫ 70 cm) equilibrated in saline (150 mM NaCl, 1 mM EDTA, pH 7.4) to separate the aggregated/fused particles from the monomers. For NMR analysis, the amino groups of lysine residues (lysine-NH 3 14 C radioactivity incorporated into the lysine residues of apoB-100.
NMR Spectroscopy-Broad band proton-decoupled 13 C NMR-free induction decay signals were measured from LDL samples comprising 2.1-20 mg of protein/ml in a solution containing 150 mM NaCl, 1 mM EDTA, and 0.02% NaN 3 , pH 7.4, and 10% of D 2 O for the spectrometer field-lock. The 13 C NMR data were obtained at 37 Ϯ 0.5°C. In all experiments, the relaxation delay was 5 s, and pulse length was 8 s (34). The spectral width of 200 ppm and the free induction decay was recorded for 0.273 s. The total acquisition time varied from 6 to 16 h, depending on the LDL concentration of the sample. Proton decoupling was performed with a GARP-1 sequence (35) . Each measured free induction decay was zero-filled twice prior to the Fourier transformation to the frequency domain spectrum. No apodization was used.
The normal and active lysines peak at 42.8 and 43.2 ppm, respectively, and the cholesterol backbone 13 C 13 peaks at 42.2 ppm were subjected to line shape fitting analysis to accurately resolve the areas of these partly overlapping peaks. Each peak was modeled with a Lorenzian basis line shape, but for each spectrum the shape was corrected for a Gaussian contribution. In addition, the phase and the base-line level were adjusted during the analysis. The total line shape option of the PERCH (PEak reseaRCH) software was used (36) . The iterative analysis resulted in a good correspondence with the experimental resonances in every case and thus the model parameters obtained could be used to derive the areas of the normal and active lysine peaks.
Electron Microscopy of LDL-Samples (3 l) were dried on carboncoated grids, after which 3 l of 1% potassium phosphotungstate, pH 7.4, was also dried on the grids (37) . The negatively stained samples were viewed and photographed in a JEOL 1200EX electron microscope at the Institute for Biotechnology, Department of Electron Microscopy, Helsinki, Finland. The diameters of 200 randomly selected lipoprotein particles were measured from the electron micrographs.
RESULTS
To study the effect of SM and PC hydrolysis of LDL particles, 1 mg/ml 3 H-LDL was first treated with 95 ng/ml (50 milliunits/ ml) SMase for 1 h at 37°C or with 50 ng/ml (60 milliunits/ml) PLA 2 in the presence of 2% BSA for 1 h at 37°C. The degrees of lipolysis produced by SMase and PLA 2 were determined from the respective amounts of phosphocholine and free fatty acid molecules formed. After incubation for 1 h, 0.28 nmol of SM/g LDL and 0.45 nmol of PC/g LDL were hydrolyzed. The aggregation and fusion of the LDL particles were determined from the turbidity of the lipolyzed samples, as measured by their absorbance at 430 nm. The absorbance of the SMase-treated LDL was markedly increased, whereas that of PLA 2 -treated LDL was not. The absorbances of native LDL, SMase-treated LDL, and PLA 2 -treated LDL were 0.325, 0.695, and 0.363, respectively. The increased turbidity of the SMase-treated LDL reflects aggregation/fusion of LDL and is in accord with previously reported results (19) .
The degree of aggregation/fusion of the lipolyzed LDL samples was determined on a Superose 6 HR 10/30 gel filtration column, whose exclusion limit is 4 ϫ 10 6 . Native LDL eluted from the gel filtration column in a single peak at 11 ml (Fig.  1A) . Surprisingly, both SMase-and PLA 2 -treated LDL eluted from the column in two peaks (Figs. 1, B and C, respectively); peak I eluted at the void volume of the column and peak II at a position corresponding to the elution volume of native LDL. The degree of aggregation/fusion of the two lipolyzed samples was quantified by expressing the amount of radioactivity eluting at the void volume of the column (peak I) in percent of the total eluted radioactivity. These calculations showed that 45% of the SMase-treated LDL and 44% of the PLA 2 -treated LDL were aggregated/fused.
To analyze the morphology of the SMase-and PLA 2 -treated LDL particles, native LDL and aliquots of the peak fractions from the gel filtration chromatography were analyzed with electron microscopy after negative staining of the particles. The size distribution of 200 particles was determined from the electron micrographs (Fig. 2, A-E) . Native LDL had a mean diameter of 21.1 nm (Ϯ1.4 nm, median 21.4 nm). The SMasetreated particles eluting in peak II resembled native LDL, and the PLA 2 -treated particles eluting in peak II were slightly smaller than native LDL. Their mean diameters were 20.7 (Ϯ2.0 nm, median 21.4 nm) and 19.5 (Ϯ2.2 nm, median 20.0 nm), respectively. The mean diameter of the SMase-treated particles eluting in peak I was 24.7 nm (Ϯ6.2 nm, median 21.4 nm). About 35% of the particles were larger than any of the particles in native LDL; the largest particles had diameters of 47 nm. In contrast, the PLA 2 -treated particles eluting in peak I resembled native LDL; their mean diameter was 20.4 nm (Ϯ2.4 nm, median 21.4 nm). Since elution of the native-sized LDL particles from the gel filtration column at the void volume reveals particle aggregation, we conclude that PLA 2 induced aggregation of LDL, whereas SMase induced both aggregation and fusion of the lipolyzed LDL particles.
We next studied the effect of the degree of LDL lipolysis on the degree of aggregation and fusion. For this purpose, 3 H-LDL was incubated with 50 milliunits/ml SMase or with 60 milliunits/ml of PLA 2 and 2% BSA for various times. At the indicated time points, lipolysis was stopped with EDTA, and the degrees of lipolysis (Fig. 3A) and aggregation/fusion (Fig. 3B) were determined. Under the above conditions, lipolysis of LDL with both SMase and PLA 2 reached a maximum after incubation for 2 h, when 0.51 nmol of PC or 0.36 nmol of SM/g LDL was hydrolyzed. The degree of aggregation/fusion was determined with gel filtration chromatography on a Superose 6 HR 10/30 column. SMase induced substantial aggregation/fusion of LDL after 1 h, when the degree of lipolysis was 85% of the maximum. In a parallel experiment, the degree of SM hydrolysis was found to be different in the two particle populations; 97% of SM in the aggregated/fused particles and 74% of SM in the monomeric particles were degraded. With prolonged incubation, the SMase-induced aggregation/fusion continued, and after incubation for 8 h, 90% of the radioactivity eluted in the void volume of the gel filtration column. After incubation for 24 h, the recovery of SMase-treated LDL from the gel filtration column was less than 50%, and the degree of aggregation/ fusion could not be determined accurately. About 50% of the particles in this sample formed large aggregates that could be sedimented by centrifugation at 14,000 ϫ g, and electron microscopic examination of the sample revealed that about 50% of the particles were enlarged (not shown). PLA 2 -induced aggregation of LDL particles reached a maximum of about 40% after incubation for as little as 2 h, the degree of lipolysis then being maximal. Even after incubation for 24 h, more than half of the PLA 2 -treated LDL remained monomeric. Recovery of the sample from the gel filtration column was over 85%, and less than 10% of the radioactivity could be sedimented by centrifugation at 14 000 ϫ g, indicating formation of small aggregates. The particles, whether eluting in peak I (void volume) or peak II, and whether the incubation time was 1 h or 24 h, were slightly smaller than native LDL (not shown). Phospholipid analysis of the peak fractions showed that, after incubation for 24 h, all of the PC in both the aggregated and monomeric PLA 2 -treated particles was hydrolyzed. When the above experiments were repeated with LDL from various donors, it was found that the degree of PLA 2 -induced aggregation varied between 16 and 3 H-LDL (600 g; 200 dpm/g protein) was incubated at 37°C for 1 h with 50 milliunits/ml SMase or with 60 milliunits/ml PLA 2 and 2% BSA. After incubation, lipolysis was stopped by addition of EDTA at a final concentration of 10 mM. Aliquots corresponding to 300 g of native or lipolyzed LDL were applied to a Superose 6 HR 10/30 column. Elution with 5 mM Tris-HCl, 1 mM EDTA, and 150 mM NaCl, pH 7.4, was carried out at 0.5 ml/min. Fractions of 500 l were collected and their radioactivities were measured (A-C).
44%. SMase-induced aggregation, on the other hand, always led to aggregation/fusion of virtually all of the lipolyzed LDL particles. Taken together, SMase induced substantial aggregation/fusion of LDL only after most of the SM molecules on the particles were hydrolyzed, but once this had taken place, all of the SMase-treated particles became aggregated and/or fused. In contrast, PLA 2 -induced aggregation of LDL began without any delay, but, even after prolonged incubation times, only a fraction of the PLA 2 -treated particles became aggregated without ensuing particle fusion.
Recently, human secretory SMase (s-SMase), secreted by arterial cells, was shown to be unable to act on native LDL at neutral pH (15) . In contrast, LDL pretreated with human secretory PLA 2 was hydrolyzed by the enzyme even at neutral pH. In preliminary experiments, we found that when LDL is treated with PLA 2 in the absence of albumin, the lipolytic products of PLA 2 activity accumulate in the LDL particles; the negatively charged free fatty acids increase the net negative charge of the PLA 2 -treated particles, and they do not aggregate (not shown). However, intimal fluid contains about 2% albumin (38) , and if LDL (1 mg/ml) is treated with PLA 2 in the presence of 2% BSA, the net charge of the particles is not increased, indicating that the negatively charged free fatty acids have been released from the particles (not shown). Therefore, to study the effect of PLA 2 pretreatment on SMase-induced aggregation/fusion of LDL, we treated LDL with immobilized PLA 2 in the presence and absence of 2% BSA for various times. At the indicated time points, the PLA 2 beads were sedimented and removed, and 50 milliunits/ml SMase was added to the supernatants. After incubation for 30 min with SMase, EDTA was added to stop the lipolysis, and incubation was continued for an additional 4 h at 37°C. The turbidity of the samples at 430 nm and the degrees of PC and SM hydrolysis were then determined. In all the samples, the degree of SM hydrolysis was similar (130 nmol Ϯ 22 nmol/g LDL), indicating that pretreatment of LDL with PLA 2 did not affect the activity of SMase on LDL. Treatment of LDL with PLA 2 in either the presence or absence of BSA did not change the turbidity of the samples, even though treatment for 30 min in the presence of albumin induced aggregation of about 20% of the LDL particles. In the absence of albumin, PLA 2 pretreatment decreased the degree of SMase-induced aggregation/fusion of LDL particles (Fig. 4, white columns) . In contrast, in the presence of albumin PLA 2 pretreatment promoted SMase-induced aggregation/fusion of LDL; the higher the degree of PC hydrolysis, the higher was the turbidity of the SMase-treated LDL particles (Fig. 4, black columns) . Thus, in physiological albumin concentration, pretreatment of LDL with PLA 2 appeared to facilitate SMase-induced aggregation/fusion of LDL.
To examine the binding of the lipolyzed particles to proteoglycans, we isolated proteoglycans from human aortas and coupled them to NHS-activated HiTrap columns to prepare affinity columns as described under the "Experimental Procedures." LDL was treated with PLA 2 or SMase for 1 h, and lipolysis was stopped with EDTA. The lipolyzed samples were separated into aggregated/fused and monomeric particles by gel filtration chromatography. Aliquots (30 l) of the lipolyzed LDL samples, aggregated/fused and monomeric particles, or, as a control, native LDL, were then applied to the proteoglycan column and eluted with a linear NaCl gradient (0 -250 mM in 10 min). Elution was monitored with UV absorbance at 280 nm and by collecting 500-l fractions and determining their radioactivities. Of the applied native LDL (60 g), 95% bound to the column and eluted as a single peak at 60 mM NaCl (Fig. 5A) .
FIG. 2.
Electron microscopic analysis of SMase-and PLA 2 -treated LDL particles. LDL (1 mg/ml) was incubated at 37°C for 1 h with 50 milliunits/ml SMase or with 60 milliunits/ml PLA 2 and 2% BSA and separated into aggregated/ fused (peak I) and monomeric (peak II) particles. The LDL particles in these different peak fractions were examined by electron microscopy after negative staining (insets in each panel), and the size distributions of the negatively stained particles were determined as described under "Experimental Procedures." A, native LDL; B, SMase-treated LDL in peak I; C, SMase-treated LDL in peak II; D, PLA 2 -treated LDL in peak I; E, PLA 2 -treated LDL in peak II. The bar under the inset in A represents 100 nm.
FIG. 3. Degrees of lipolysis and aggregation/fusion of LDL induced by incubation with SMase or PLA 2 .
3 H-LDL (300 g; 100 dpm/g protein) was incubated with 50 milliunits/ml SMase or 60 milliunits/ml PLA 2 and 2% BSA at 37°C. At the indicated time points, lipolysis was stopped with EDTA. The degrees of lipolysis were determined as the amounts of phosphocholines or free fatty acids, respectively (A). The degree of aggregation/fusion (% of total) was determined as the amount of LDL radioactivity eluting in the void volume of a Superose 6 HR 10/30 gel filtration column, as described under "Experimental Procedures."
The SMase-treated sample, on the other hand, eluted from the proteoglycan column in two peaks, the first peak at 60 mM NaCl and the second peak at 100 mM NaCl (Fig. 5B) . The PLA 2 -treated sample eluted from the column in two overlapping peaks at 55 and 75 mM NaCl (Fig. 5C ). The arrows in Fig. 5 show the elution volumes of the aggregated/fused and monomeric particles; both PLA 2 -and SMase-treated aggregated/ fused particles eluted at higher salt concentration than either native LDL or the lipolyzed LDL monomers. Thus, lipolysis alone did not change the strength of binding of LDL to proteoglycans, but the aggregated/fused particles bound more tightly than native LDL to proteoglycans. Furthermore, the strength of binding of aggregated and fused SMase-treated particles was still higher than that of aggregated PLA 2 -treated particles.
Binding of LDL to proteoglycans is governed by ionic interactions between the positively charged lysine and arginine residues of apoB-100 and the negatively charged sulfate and carboxyl groups of the proteoglycans (39 -42) . Binding of native LDL to proteoglycans can be blocked by removing the positive charge of the lysine or arginine residues in the apoB-100 (43) . Similarly, when SMase-or PLA 2 -treated LDL particles were treated with acetic anhydride to remove the positive charge of the lysine residues, the lipolyzed LDL particles did not bind to the proteoglycan column (not shown). The lysine residues on apoB-100 are of two forms having different pK a values, and it is the active lysines having a pK a of 8.9 that are thought to be involved in the binding of LDL to proteoglycans (7, 9, 33) . The two lysine populations can be quantified with 13 C NMR spectroscopy, after attachment of two [ 13 C]methyl groups to the lysine residues. We used this NMR method to gain information about the effects of SM and PC hydrolysis on the two lysine populations. For this purpose, 20 or 40 mg of LDL (2 mg/ml) was incubated with SMase or PLA 2 , respectively, for 8 h at 37°C. After incubation, lipolysis was stopped by addition of EDTA, and the samples were concentrated with Amicon 100 microconcentrators and applied to a Bio-Gel A-5m (1 ϫ 50) gel filtration column. Most of the SMase-lipolyzed LDL eluted at the void volume of the column, and PLA 2 -lipolyzed LDL eluted as two peaks as follows: the aggregated particles (peak I at the void volume of the column) and the monomeric particles (peak II). The three lipolyzed samples, namely SMase-treated aggregated/fused, PLA 2 -treated aggregated, and PLA 2 -treated monomeric LDL particles, were labeled with [
13 C]formaldehyde to add [ 13 C]methyl groups to the lysine residues of apoB-100. As a control, native LDL was also labeled with [ 13 C]formaldehyde. Determination of the size distribution of the samples with electron microscopy revealed that the diameters of native LDL and both aggregated and monomeric PLA 2 -lipolyzed LDL were similar (Table I) . Approximately 50% of the SMase-treated particles were enlarged. The largest particles had diameters of 45 nm.
The NMR spectrum of the 13 C-labeled LDL showed lipid resonances and, at 43.2 and 42.8 ppm, [ 13 C]dimethyl lysine resonances (Fig. 6 ), in accord with the results of Lund-Katz et al. (33) , who showed that these resonances were those of active and normal lysine residues, respectively. The NMR spectra of 13 C-labeled SMase-lipolyzed LDL, aggregated PLA 2 -lipolyzed LDL, and monomeric PLA 2 -lipolyzed LDL showed similar resonances. Fig. 6 , A-D, shows enlargements of the [
13 C]dimethyl lysine resonances. The areas of these two resonances give the percentages of active and normal lysine residues in the samples; these are expressed in relation to the amount of protein (Table I) . When calculated per apoB-100 moiety, the number of active lysine residues in native LDL was 11. The numbers of active lysine residues in the monomeric and the aggregated PLA 2 -lipolyzed LDL were 11 and 10, respectively. The number of active lysine residues per apoB-100 in the SMase-treated aggregated/fused particles was 40. Each aggregate contains several LDL particles and consequently several copies of apoB-100. Even when some of the lipolyzed LDL particles are buried within the aggregate and so cannot interact with proteoglycans, each aggregate contains several apoB-100 moieties that can take part in the binding of the aggregate to proteoglycans. Accordingly, the number of active lysine residues available for the binding is higher per aggregate than per monomeric particle. However, since we lack a method for determining the number of LDL particles per aggregate, the number of active lysines per aggregate cannot be estimated. In contrast, the effect of particle fusion can be estimated. During fusion, apoB-100 moieties of several LDL particles accumulate on the surface of the fusing particle. The average diameters of native LDL and SMase-lipolyzed LDL were 20.4 and 25.7 nm, respectively (Table I) . Of the SMase-treated particles, 50% were larger than any of the native LDL particles, and their mean diameter was 30.5 nm. If the diameter of a spherical particle increases from 20.4 to 30.5 nm, its volume increases 3.3-fold. Thus, one fused particle with a diameter of 30.5 nm results from coalescence of an average of 3.3 native-sized particles and contains 3.3 apoB-100 molecules per fused particle. Accordingly, the number of active lysine residues in such a fused particle must also be 3.3 times as high, i.e. 3.3 ϫ 40 ϭ 132. Thus, the above calculations revealed that, in the SMase-treated fused particles, the number of active lysine residues is increased by approximately 12-fold in comparison to native LDL.
DISCUSSION
Interactions between native LDL particles do not lead to aggregation or fusion of the particles. If the structure of LDL is modified, however, particle interactions may favor aggregation, which may then lead to particle fusion. The lipolytic modifications studied in this work induced substantial changes in the composition and surface structure of LDL particles; SMase cleaved SM into phosphocholine and ceramide molecules, and PLA 2 hydrolyzed the fatty acids in the sn-2 position of PC, FIG. 4 . Effect of PLA 2 pretreatment on the SMase-induced aggregation and fusion of LDL. Immobilized PLA 2 (25 milliunits) was added to 500 g of LDL in 500 l of buffer A containing 5 mM CaCl 2 and 2 mM MgCl 2 in the presence and absence of 2% BSA. At the indicated time points, the PLA 2 beads were sedimented and removed, and 20 milliunits of SMase was added to 400 l of the supernatants. After incubation for 30 min with SMase, the lipolysis was stopped with EDTA, and incubation was continued for an additional 4 h at 37°C. The turbidity of the samples at 430 nm and the degrees of PC and SM hydrolysis were determined from duplicate samples. The maximum deviations from the means were 0.026 absorbance units and 3.5 nmol of free fatty acids/g of LDL.
generating free fatty acid and lyso-PC molecules. Both of these lipolytic modifications led to aggregation and/or fusion of LDL, but the aggregation and fusion behavior of the lipolyzed particles was dissimilar, i.e. treatment of LDL with PLA 2 induced particle aggregation only, whereas lipolysis with SMase induced aggregation and subsequent fusion of the lipolyzed particles.
Aggregation of SMase-treated LDL particles has been shown to depend on the accumulation of ceramide within the particles and does not require the apoB-100 component (14) . In PC bilayers, ceramide is known to induce lateral phase separation into regions of liquid crystalline and gel phases (44) . Importantly, ceramide is largely partitioned in the resultant gel phase, and SM molecules do not cause such microdomain formation (44) . Since the SM molecules on an LDL cover only approximately 15% of the surface volume of the particle, it is likely that, for the formation of ceramide-enriched microdomains, a substantial proportion of the SM molecules must be hydrolyzed. These microdomains, however, once formed, could act as nonpolar spots at the surface of the particles and lead to particle aggregation through hydrophobic associations between the domains. When the LDL particles become aggregated, the surface lipid environments of the attached particles will become connected, and diffusion of the lipid molecules between the particles can commence. Energetic stabilization can then drive subsequent fusion of the attached particles. This kind of structural reorganization at the surface of SMase-treated LDL particles can thus explain the finding that substantial aggregation/fusion of LDL occurs only after a substantial proportion of the SM molecules of the particles has been hydrolyzed.
Treatment of LDL with SMase at low temperature (15°C) does not lead to aggregation of the particles even though SM is hydrolyzed. 2 However, if these SMase-treated particles are subsequently incubated at 37°C, they aggregate and fuse. This is understood by the interactions between the core and surface lipids of the LDL particles. It is known that a few percent of the core lipids penetrate to the surface in native LDL (45) . At 15°C the core lipids of LDL are in a radially ordered liquid crystalline phase and at 37°C in a liquid-like state. Therefore, at the lower temperature, the oriented rigid core lipids interacting with the surface monolayer of the particles can substantially 2 K. Ö örni and P. T. Kovanen, unpublished observations. 3 H-LDL (400 g; 250 dpm/g protein) was incubated with 30 milliunits of SMase or 36 milliunits of PLA 2 and 2% BSA for 1 h at 37°C. Lipolysis was stopped with EDTA, and a fraction of the lipolyzed samples was separated into aggregated/fused and monomeric particles by gel filtration chromatography on a Superose 6 HR 10/30 column (see Fig. 1 ). Aliquots (30-l) of native LDL, lipolyzed samples, or peak fractions of the gel filtration chromatography were applied to an NHS-activated HiTrap (1 ml) column to which human aortic proteoglycans had been coupled. The strengths of binding of the samples to the proteoglycans were examined by eluting the LDL at 1 ml/min using a linear NaCl gradient (0 -250 mM) in buffer B. Elution was monitored by UV absorbance at 280 nm and by collecting fractions and determining their radioactivity (inset in each panel). inhibit lateral diffusion of the surface phospholipids (46) . Consequently, formation of the ceramide-enriched microdomains should also be at least partly inhibited. Thus, the observed behavior of SMase-treated LDL below and above the transition temperature of the core lipids gives further support to the idea that the initial SMase-induced aggregation takes place via the formation of hydrophobic ceramide-enriched microdomains at the surface of the modified LDL particles.
Hydrolysis of PC by PLA 2 did not alone trigger aggregation of LDL particles. For particle aggregation to occur, the majority of the fatty acids formed, and some of the lyso-PC molecules had to be released from the particles. The negatively charged fatty acids are likely to prevent the particles from aggregating by causing repulsions between them. An observation consistent with this idea is that acetylated, negatively charged LDL is resistant to aggregation and fusion when treated with sphingomyelinase (19) . In the presence of 2% BSA, which is the concentration of albumin in physiological extracellular fluids, such as the intimal fluid (38) , the PLA 2 -treated LDL particles aggregated. At this albumin concentration, lipolysis of LDL did not change the net charge of the LDL particles, since the negatively charged fatty acids were released from the particles. Treatment of LDL with PLA 2 at a low temperature in the presence of 2% BSA (15°C) did not inhibit particle aggregation. 2 Thus, unlike SMase-induced aggregation of LDL particles, PLA 2 -induced aggregation seems not to depend on surface microdomain formation dependent on lateral lipid diffusion. Interestingly, PLA 2 -treated aggregation did not lead to particle fusion. An explanation consistent with these findings would be that the apoB-100 moiety of LDL is involved in the PLA 2 -induced aggregation of LDL. In fact, treatment of LDL with PLA 2 has been reported to induce changes in the conformation of apoB-100 (47) . Thus, the apoB-100 moieties of the lipolyzed particles could prohibit contact between the lipids of the aggregated particles, preventing lipid diffusion between the particles and thus also subsequent particle fusion.
Both PLA 2 -and SMase-treated aggregated/fused particles showed increased strength of binding to proteoglycans. However, mere lipolysis of LDL, with either SMase or PLA 2 , did not affect the strength of particle binding to proteoglycans. LDL is known to bind to proteoglycans via ionic interactions between the positively charged lysine-and arginine-containing segments of apoB-100 and the negatively charged sulfate and After incubation, lipolysis was stopped with EDTA, and the samples were applied to a Bio-Gel A5-m gel filtration column. PLA 2 -treated sample eluted in two peaks (peak I at the void volume of the column) and SMase-treated sample in one peak at the void volume of the column. The peak fractions were pooled and labeled with [
13 C]formaldehyde to add [
13 C]methyl groups to the lysine residues of apoB-100. As a control, native LDL was also labeled with [ 13 C]formaldehyde. The 13 C NMR data (at 150.8 MHz) were recorded at 37 Ϯ 0.5°C, as described in detail under "Experimental Procedures." The resonances in the 13 C NMR spectrum of LDL are shown at the bottom. The enlargements illustrate the dimethyl lysine peaks for LDL (A), PLA 2 -treated monomeric LDL (B), PLA 2 -treated aggregated LDL (C), and SMase-treated LDL (D). In LDL 49.1%, i.e. 175 of the total of 357 lysine residues in apoB-100, were methylated and detectable in the NMR spectra. The corresponding values in PLA 2 -treated LDL monomers were 62.7% (224), in PLA 2 -treated aggregated LDL 85.0% (303), and in SMasetreated aggregated/fused LDL 52.8% (188).
TABLE I
The number of active and normal lysines in PLA 2 -and SMase-treated LDL particles The percentages of active and normal lysine residues in LDL, PLA 2 -treated monomeric and aggregated LDL, and SMase-treated aggregated/ fused LDL were derived from the areas of the [ 13 C]dimethyl lysine peaks shown in Fig. 6 . The numbers of lysines were calculated from the percentages and rounded to the nearest integer. The areas are accurate to Ϯ4 -14% for the active lysines and Ϯ1-3% for the normal lysines. In the SMase-treated aggregated/fused LDL sample, 50% of the particles had diameters of more than 25 nm and were larger than any of the particles in the control LDL sample. The mean diameter of these fused particles was 30.5 nm. The rest of the particles in the SMase-treated sample were regarded as aggregates, and their mean diameter was 21.0 nm. The number of normal and active lysine residues per particle was calculated separately for these particle populations. carboxyl groups of the proteoglycans (39 -42) . The likely reasons for the observed increase in the binding strength are thus more ionic interactions or stronger ionic interactions between apoB-100 of lipolyzed LDL particles and the proteoglycans. A specific population of lysine residues, active lysines, has been suggested to be involved in the binding of LDL to proteoglycans (33) . Therefore, the number of active lysines may reflect the number of potential proteoglycan-binding sites. Indeed, we previously (7, 9) found that the number of active lysines correlated positively with the strength of binding of LDL to human aortic proteoglycans. Similarly, as shown in this study, in the SMasetreated aggregated/fused particles, the number of active lysine residues was increased. In contrast, in the PLA 2 -treated aggregated LDL particles the number of active lysines was not increased even though the strength of binding to proteoglycans was enhanced. This apparent discrepancy can be explained by the fact that each aggregate contains several LDL particles and thereby several copies of apoB-100. Accordingly, the number of active lysine residues available for binding is higher per aggregate than per monomeric particle. Similarly, in the case of SMase, both aggregation and fusion of the lipolyzed particles increase the number of apoB-100 moieties per aggregate and per fused particle. Taken together, the increased number of active lysine residues provides a plausible explanation for the observed increase in the strength of binding of both PLA 2 -treated aggregated and SMase-treated aggregated/fused particles to proteoglycans. Secretory SMase has recently been extensively studied by Tabas and co-workers (14, 15, 48, 49) . This enzyme has an acidic pH optimum and cannot hydrolyze native LDL at neutral pH (15) . However, LDL modified with secretory PLA 2 or by oxidation is hydrolyzed with the s-SMase at neutral pH. In the present study, we have shown that treatment of LDL with bee venom PLA 2 in the presence of a physiological concentration of albumin induces aggregation of LDL particles and also increases SMase-induced aggregation and fusion of the LDL particles. Similarly, if PLA 2 hydrolyzes LDL phospholipids in vivo, the threshold for SMase-induced lipoprotein aggregation and subsequent fusion could be lowered. In addition, the increased strength of binding of the PLA 2 -treated aggregated LDL particles to arterial proteoglycans may increase the residence time of the aggregated particles in the arterial intima and so make them more susceptible to further enzymatic attack by s-SMase. Since SMase-treated aggregated/fused LDL particles bind to proteoglycans even more tightly than PLA 2 -treated aggregated LDL, SMase-induced aggregation and fusion of LDL particles may then lead to further retention of the modified LDL within the extracellular proteoglycans. Moreover, the combined action of PLA 2 and SMase on LDL can produce aggregated lipid droplets having both an increased SM-to-PC ratio and an increased content of ceramide. Such particles resemble, both chemically and morphologically, the extracellular aggregated lipid droplets found in atherosclerotic arteries. Therefore, a tentative pathway resulting in tight binding of LDL to arterial proteoglycans in vivo and so leading to focal retention and accumulation of extracellular lipid in the arterial intima is aggregation and fusion of LDL induced by the consecutive action of PLA 2 and SMase.
